Picture of Kyung Nam Pharm Co logo

053950 Kyung Nam Pharm Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for Kyung Nam Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-4,546-5,488-3,413-6,779-22,228
Depreciation
Amortisation
Non-Cash Items2,8078,839-1,4924,47016,410
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-5,805-2,262-6,2674203,653
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-6,4252,615-9,34271.6693
Capital Expenditures-1,334-18,121-2,637-2,918-4,177
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items2,143-31,9461,368-304-39,834
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities809-50,067-1,269-3,222-44,010
Financing Cash Flow Items-32.41,203-48.6-587531
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities21,13446,30710,75623,26126,146
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash15,520-1,20920320,061-17,032